Showing papers by "Jana Markova published in 2005"

TL;DR: It is suggested that 2 chemotherapy cycles with involved field radiotherapy may be sufficient for patients with early favourable HL, but a reliable assessment must await the final analysis including all randomised patients and with adequate follow-up.

TL;DR: At three years of median observation time, no sequential significant differences in treatment outcome were detected, neither between chemotherapy regimens nor between the different doses of radiotherapy, despite more relapses in 20 Gy radiotherapy arms.

TL;DR: MRD quantitation of IgVH expression using SG-based RQ-PCR represents a highly specific, sensitive, and economic alternative to the current quantitative methods.